Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115


In vivo structural and functional assessment of optic nerve damage in neuromyelitis optica spectrum disorders and multiple sclerosis.

Vabanesi M, Pisa M, Guerrieri S, Moiola L, Radaelli M, Medaglini S, Martinelli V, Comi G, Leocani L.

Sci Rep. 2019 Jul 17;9(1):10371. doi: 10.1038/s41598-019-46251-3.


Thickness of macular inner retinal layers and peripapillary retinal nerve fibre layer in neuromyelitis optica spectrum optic neuritis and isolated optic neuritis with one episode.

Peng C, Wang W, Xu Q, Yang M, Zhou H, Zhao S, Wei S.

Acta Ophthalmol. 2017 Sep;95(6):583-590. doi: 10.1111/aos.13257. Epub 2016 Oct 24.


Differing Structural and Functional Patterns of Optic Nerve Damage in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.

Shen T, You Y, Arunachalam S, Fontes A, Liu S, Gupta V, Parratt J, Wang C, Barnett M, Barton J, Chitranshi N, Zhu L, Fraser CL, Graham SL, Klistorner A, Yiannikas C.

Ophthalmology. 2019 Mar;126(3):445-453. doi: 10.1016/j.ophtha.2018.06.022. Epub 2018 Jul 27.


A prospective case-control study comparing optical coherence tomography characteristics in neuromyelitis optica spectrum disorder- optic neuritis and idiopathic optic neuritis.

Zhao X, Qiu W, Zhang Y, Luo Y, Zhang X, Lu L, Yang H.

BMC Ophthalmol. 2018 Sep 14;18(1):247. doi: 10.1186/s12886-018-0902-3.


Retinal Degeneration After First-Ever Optic Neuritis Helps Differentiate Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.

Kim NH, Kim HJ, Park CY, Jeong KS.

Front Neurol. 2019 Oct 10;10:1076. doi: 10.3389/fneur.2019.01076. eCollection 2019.


Quantifying visual pathway axonal and myelin loss in multiple sclerosis and neuromyelitis optica.

Manogaran P, Vavasour IM, Lange AP, Zhao Y, McMullen K, Rauscher A, Carruthers R, Li DKB, Traboulsee AL, Kolind SH.

Neuroimage Clin. 2016 May 26;11:743-750. doi: 10.1016/j.nicl.2016.05.014. eCollection 2016.


Optical Coherence Tomography versus Visual Evoked Potentials for Detecting Visual Pathway Abnormalities in Patients with Neuromyelitis Optica Spectrum Disorder.

Kim NH, Kim HJ, Park CY, Jeong KS, Cho JY.

J Clin Neurol. 2018 Apr;14(2):200-205. doi: 10.3988/jcn.2018.14.2.200. Epub 2018 Feb 28.


Structural and visual functional deficits in a rat model of neuromyelitis optica spectrum disorders related optic neuritis.

Zhang Y, Bao Y, Qiu W, Peng L, Fang L, Xu Y, Yang H.

Exp Eye Res. 2018 Oct;175:124-132. doi: 10.1016/j.exer.2018.06.011. Epub 2018 Jun 18.


MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients.

Pache F, Zimmermann H, Mikolajczak J, Schumacher S, Lacheta A, Oertel FC, Bellmann-Strobl J, Jarius S, Wildemann B, Reindl M, Waldman A, Soelberg K, Asgari N, Ringelstein M, Aktas O, Gross N, Buttmann M, Ach T, Ruprecht K, Paul F, Brandt AU; in cooperation with the Neuromyelitis Optica Study Group (NEMOS).

J Neuroinflammation. 2016 Nov 1;13(1):282.


A comparative optical coherence tomography study in neuromyelitis optica spectrum disorder and multiple sclerosis.

Outteryck O, Majed B, Defoort-Dhellemmes S, Vermersch P, Zéphir H.

Mult Scler. 2015 Dec;21(14):1781-93. doi: 10.1177/1352458515578888. Epub 2015 Mar 31.


Optical Coherence Tomography and Magnetic Resonance Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.

Manogaran P, Hanson JV, Olbert ED, Egger C, Wicki C, Gerth-Kahlert C, Landau K, Schippling S.

Int J Mol Sci. 2016 Nov 15;17(11). pii: E1894. Review.


Optical Coherence Tomography Reveals Distinct Patterns of Retinal Damage in Neuromyelitis Optica and Multiple Sclerosis.

Schneider E, Zimmermann H, Oberwahrenbrock T, Kaufhold F, Kadas EM, Petzold A, Bilger F, Borisow N, Jarius S, Wildemann B, Ruprecht K, Brandt AU, Paul F.

PLoS One. 2013 Jun 21;8(6):e66151. doi: 10.1371/journal.pone.0066151. Print 2013.


High resolution retinal scanning reveals regional structural differences between MS and NMOSD optic neuritis regardless of antibody status.

Bertsch-Gout M, Loeb R, Finch AK, Javed A, Bernard J.

J Neurol Sci. 2018 Jan 15;384:61-66. doi: 10.1016/j.jns.2017.11.017. Epub 2017 Nov 15.


Quantification of retinal neural loss in patients with neuromyelitis optica and multiple sclerosis with or without optic neuritis using Fourier-domain optical coherence tomography.

Monteiro ML, Fernandes DB, Apóstolos-Pereira SL, Callegaro D.

Invest Ophthalmol Vis Sci. 2012 Jun 26;53(7):3959-66. doi: 10.1167/iovs.11-9324.


Severe structural and functional visual system damage leads to profound loss of vision-related quality of life in patients with neuromyelitis optica spectrum disorders.

Schmidt F, Zimmermann H, Mikolajczak J, Oertel FC, Pache F, Weinhold M, Schinzel J, Bellmann-Strobl J, Ruprecht K, Paul F, Brandt AU.

Mult Scler Relat Disord. 2017 Jan;11:45-50. doi: 10.1016/j.msard.2016.11.008. Epub 2016 Nov 20.


Differences in clinical features between optic neuritis in neuromyelitis optica spectrum disorders and in multiple sclerosis.

Srikajon J, Siritho S, Ngamsombat C, Prayoonwiwat N, Chirapapaisan N; Siriraj Neuroimmunology Research Group.

Mult Scler J Exp Transl Clin. 2018 Aug 11;4(3):2055217318791196. doi: 10.1177/2055217318791196. eCollection 2018 Jul-Sep.


Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis.

Syc SB, Saidha S, Newsome SD, Ratchford JN, Levy M, Ford E, Crainiceanu CM, Durbin MK, Oakley JD, Meyer SA, Frohman EM, Calabresi PA.

Brain. 2012 Feb;135(Pt 2):521-33. doi: 10.1093/brain/awr264. Epub 2011 Oct 17.


Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies.

Ratchford JN, Quigg ME, Conger A, Frohman T, Frohman E, Balcer LJ, Calabresi PA, Kerr DA.

Neurology. 2009 Jul 28;73(4):302-8. doi: 10.1212/WNL.0b013e3181af78b8.


Association of Optic Neuritis with Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis in Korea.

Kim H, Park KA, Oh SY, Min JH, Kim BJ.

Korean J Ophthalmol. 2019 Feb;33(1):82-90. doi: 10.3341/kjo.2018.0050.

Supplemental Content

Support Center